BTL launches EXOLASE ONE, the world’s first fused‑erbium laser, creating a new platform for facial rejuvenation treatments
Executive summary: BTL established a new laser division and introduced EXOLASE ONE, the world’s first fused‑erbium laser for facial rejuvenation. The device combines multiple wavelengths into a single beam, which BTL says sets a new standard of care in laser‑based aesthetic treatments.
Who is involved: BTL (the medical‑aesthetic technology company), its laser division team, and the PR Newswire distribution network.
Likely next: BTL will pursue regulatory clearances and begin commercial rollout of EXOLASE ONE in selected markets, though specific timelines were not provided.
On September 2, 2026, BTL announced the formation of a dedicated laser division and unveiled EXOLASE ONE, a device that combines multiple wavelengths into a single beam for laser facial rejuvenation. The company claims the technology sets a new standard of care in the aesthetic laser market. The announcement was simultaneously distributed in English, French, and German via PR Newswire, indicating a broad international launch. No regulatory approvals or launch timelines were disclosed in the releases.
Timeline
- — BTL gründet neue Lasersparte und stellt EXOLASE ONE® vor - den weltweit ersten Fused-Erbium-Laser (PR Newswire)
- — BTL crée une nouvelle division dédiée au laser et lance EXOLASE ONE® - le premier laser à erbium fusionné au monde (PR Newswire)
- — BTL Establishes New Laser Division and Introduces EXOLASE ONE® - The World's First Fused Erbium Laser (PR Newswire)
Key entities
Sources
Open the full interactive case file on Beyond →